Display options
Share it on
Full text links
Elsevier Science

Food Chem Toxicol. 1989 Jan;27(1):21-6. doi: 10.1016/0278-6915(89)90087-2.

Histopathological evaluation of proliferative liver lesions in rats fed trans-anethole in chronic studies.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

P M Newberne, W W Carlton, W R Brown

Affiliations

  1. Department of Pathology, Boston University School of Medicine, MA 002118.

PMID: 2467866 DOI: 10.1016/0278-6915(89)90087-2

Abstract

In a two-year study of rats fed trans-anethole--a flavouring that is Generally Recognized As Safe by the US Food and Drug Administration--a slight increase in proliferative lesions of the liver was observed. These results were reviewed by a Pathology Working Group (PWG) and their findings are detailed here. The increased incidence of non-neoplastic lesions in male and female rats fed 0.25, 0.5 or 1.0% trans-anethole was considered by the PWG to be treatment related. Male and female rats fed 0.25% trans-anethole in their diet (25 to 29 times the postulated maximum human intake) had no significant treatment-related microscopic lesions in the liver, although there was a slight increase in parenchymal cell hyperplasia. Rats fed 0.5% trans-anethole had hepatic changes consistent with those caused by chronic exposure of rodents to compounds with enzyme-inducing activity. Male and female rats fed 1.0% trans-anethole revealed increased incidence and severity of hepatic changes as seen in the mid-dose rats, and a low incidence of hepatocellular neoplasms. These neoplasms were not increased in male rats in any dietary group or in female rats of the low- (0.25%) and mid-dose (0.5%) groups. The slightly increased incidence of hepatocellular neoplasms in the high-dose females is not considered to be of significance to human safety and it is concluded that trans-anethole does not constitute a carcinogenic risk for man. The slightly increased tumour incidence was seen only in the highest dose group of one sex; it has not been observed in studies of mice fed trans-anethole--the metabolism of trans-anethole in the mouse is similar to that in man. The extremely high exposure was associated with other liver changes which may have contributed to the findings.

Similar articles

Show all 55 similar articles

Substances

MeSH terms

Publication Types

LinkOut - more resources